Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Oral Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Oral Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Oral Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Oral Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Oral Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Oral Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Oral Vaccine development has been the leading industry trend of Oral Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Oral Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Others |
| By Application Outlook |
Public, Private, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Oral Vaccine Market, By Type
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Others
Oral Vaccine Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Oral Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oral Vaccine Market Size Growth Rate by Product
1.4.2 Rotavirus Vaccine
1.4.3 Cholera Vaccine
1.4.4 Oral Polio Vaccine
1.4.5 Others
1.5 Market by End User
1.5.1 Global Oral Vaccine Market Size Growth Rate by End User
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Vaccine Market Size
2.1.1 Global Oral Vaccine Revenue 2017-2027
2.1.2 Global Oral Vaccine Sales 2017-2027
2.2 Oral Vaccine Growth Rate by Regions
2.2.1 Global Oral Vaccine Sales by Regions
2.2.2 Global Oral Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Oral Vaccine Sales by Manufacturers
3.1.1 Oral Vaccine Sales by Manufacturers
3.1.2 Oral Vaccine Sales Market Share by Manufacturers
3.1.3 Global Oral Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Oral Vaccine Revenue by Manufacturers
3.2.1 Oral Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 Oral Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 Oral Vaccine Price by Manufacturers
3.4 Oral Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Oral Vaccine Sales by Product
4.2 Global Oral Vaccine Revenue by Product
4.3 Oral Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Oral Vaccine Breakdown Data by End User
6 North America
6.1 North America Oral Vaccine by Countries
6.1.1 North America Oral Vaccine Sales by Countries
6.1.2 North America Oral Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oral Vaccine by Product
6.3 North America Oral Vaccine by End User
7 Europe
7.1 Europe Oral Vaccine by Countries
7.1.1 Europe Oral Vaccine Sales by Countries
7.1.2 Europe Oral Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Vaccine by Product
7.3 Europe Oral Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Oral Vaccine by Countries
8.1.1 Asia Pacific Oral Vaccine Sales by Countries
8.1.2 Asia Pacific Oral Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oral Vaccine by Product
8.3 Asia Pacific Oral Vaccine by End User
9 Central & South America
9.1 Central & South America Oral Vaccine by Countries
9.1.1 Central & South America Oral Vaccine Sales by Countries
9.1.2 Central & South America Oral Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oral Vaccine by Product
9.3 Central & South America Oral Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccine by Countries
10.1.1 Middle East and Africa Oral Vaccine Sales by Countries
10.1.2 Middle East and Africa Oral Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oral Vaccine by Product
10.3 Middle East and Africa Oral Vaccine by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Oral Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.2.4 GSK Oral Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Sanofi Oral Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Details
11.4.2 Company Business Overview
11.4.3 Lanzhou Institute Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Lanzhou Institute Oral Vaccine Products Offered
11.4.5 Lanzhou Institute Recent Development
11.5 Serum Institute
11.5.1 Serum Institute Company Details
11.5.2 Company Business Overview
11.5.3 Serum Institute Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Serum Institute Oral Vaccine Products Offered
11.5.5 Serum Institute Recent Development
11.6 Valneva
11.6.1 Valneva Company Details
11.6.2 Company Business Overview
11.6.3 Valneva Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Valneva Oral Vaccine Products Offered
11.6.5 Valneva Recent Development
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Details
11.7.2 Company Business Overview
11.7.3 Shanghai United Cell Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Shanghai United Cell Oral Vaccine Products Offered
11.7.5 Shanghai United Cell Recent Development
11.8 Bibcol
11.8.1 Bibcol Company Details
11.8.2 Company Business Overview
11.8.3 Bibcol Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Bibcol Oral Vaccine Products Offered
11.8.5 Bibcol Recent Development
11.9 PaxVax
11.9.1 PaxVax Company Details
11.9.2 Company Business Overview
11.9.3 PaxVax Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.9.4 PaxVax Oral Vaccine Products Offered
11.9.5 PaxVax Recent Development
11.10 Vabiotech
11.10.1 Vabiotech Company Details
11.10.2 Company Business Overview
11.10.3 Vabiotech Oral Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Vabiotech Oral Vaccine Products Offered
11.10.5 Vabiotech Recent Development
11.11 Tiantan Biological
11.12 EuBiologics
11.13 Panacea Biotec Ltd
11.14 Bio-Med
11.15 Halfkin Bio-Pharmaceuticals
12 Future Forecast
12.1 Oral Vaccine Market Forecast by Regions
12.1.1 Global Oral Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global Oral Vaccine Revenue Forecast by Regions 2021-2027
12.2 Oral Vaccine Market Forecast by Product
12.2.1 Global Oral Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global Oral Vaccine Revenue Forecast by Product 2021-2027
12.3 Oral Vaccine Market Forecast by End User
12.4 North America Oral Vaccine Forecast
12.5 Europe Oral Vaccine Forecast
12.6 Asia Pacific Oral Vaccine Forecast
12.7 Central & South America Oral Vaccine Forecast
12.8 Middle East and Africa Oral Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
